Phase II trial evaluating the efficacy of durvalumab (MEDI4736) as second-line therapy in Non- Small-Cell Lung Cancer patients receiving concomitant steroids
Latest Information Update: 13 Jul 2021
At a glance
- Drugs Durvalumab (Primary) ; Prednisone
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms STARDUST
- 13 Jul 2021 New trial record